Found: 60
Select item for more details and to access through your institution.
Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent, and young adult patients with B-cell acute lymphoblastic leukemia.
- Published in:
- Pediatric Nephrology, 2024, v. 39, n. 8, p. 2495, doi. 10.1007/s00467-024-06331-7
- By:
- Publication type:
- Article
We do not see evidence for the presence of female gametangia (oospores) in North American Nitellopsis obtusa (Desvaux) J. Groves.
- Published in:
- Botany, 2024, v. 102, n. 2, p. 52, doi. 10.1139/cjb-2023-0102
- By:
- Publication type:
- Article
Cytokine Modification of Adoptive Chimeric Antigen Receptor Immunotherapy for Glioblastoma.
- Published in:
- Cancers, 2023, v. 15, n. 24, p. 5852, doi. 10.3390/cancers15245852
- By:
- Publication type:
- Article
Chloroplast genome evolution and phylogeny of the early‐diverging charophycean green algae with a focus on the Klebsormidiophyceae and Streptofilum.
- Published in:
- Journal of Phycology, 2023, v. 59, n. 6, p. 1133, doi. 10.1111/jpy.13359
- By:
- Publication type:
- Article
Synapse-tuned CARs enhance immune cell anti-tumor activity.
- Published in:
- Nature Biotechnology, 2023, v. 41, n. 10, p. 1434, doi. 10.1038/s41587-022-01650-2
- By:
- Publication type:
- Article
Allogeneic CD34<sup>+</sup> selected hematopoietic stem cell boost following CAR T‐cell therapy in a patient with prolonged cytopenia and active infection.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 3, p. 1, doi. 10.1002/pbc.30166
- By:
- Publication type:
- Article
Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX Models.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.880108
- By:
- Publication type:
- Article
Infectious Complications in Pediatric, Adolescent and Young Adult Patients Undergoing CD19-CAR T Cell Therapy.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.845540
- By:
- Publication type:
- Article
CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28243-6
- By:
- Publication type:
- Article
Cytolytic Activity of CAR T Cells and Maintenance of Their CD4+ Subset Is Critical for Optimal Antitumor Activity in Preclinical Solid Tumor Models.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4301, doi. 10.3390/cancers13174301
- By:
- Publication type:
- Article
Hemophagocytic lymphohistiocytosis‐like toxicity (carHLH) after CD19‐specific CAR T‐cell therapy.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 4, p. 701, doi. 10.1111/bjh.17662
- By:
- Publication type:
- Article
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T Cells.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.691741
- By:
- Publication type:
- Article
Engineered Cytokine Signaling to Improve CAR T Cell Effector Function.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.684642
- By:
- Publication type:
- Article
Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 6, p. 999, doi. 10.1093/neuonc/noaa278
- By:
- Publication type:
- Article
Allogeneic CAR Cell Therapy—More Than a Pipe Dream.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.618427
- By:
- Publication type:
- Article
A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell Therapy.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00262
- By:
- Publication type:
- Article
Harnessing T Cells to Target Pediatric Acute Myeloid Leukemia: CARs, BiTEs, and Beyond.
- Published in:
- Children, 2020, v. 7, n. 2, p. 1, doi. 10.3390/children7020014
- By:
- Publication type:
- Article
IMMU-13. CRISPR/CAS9-MEDIATED SILENCING OF SHP-1 SIGNIFICANTLY ENHANCES THE ANTI-GLIOMA ACTIVITY OF IL-13Rα2 CAR T CELLS.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii95, doi. 10.1093/neuonc/noz036.134
- By:
- Publication type:
- Article
IMMU-14. IMPLICATIONS FOR T-CELL IMMUNOTHERAPY: CELL SURFACE ANTIGEN AND HLA class I EXPRESSION IN PEDIATRIC BRAIN TUMORS ARE HETEROGENOUS.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii96, doi. 10.1093/neuonc/noz036.135
- By:
- Publication type:
- Article
Engineering for Success: Approaches to Improve Chimeric Antigen Receptor T Cell Therapy for Solid Tumors.
- Published in:
- Drugs, 2019, v. 79, n. 4, p. 401, doi. 10.1007/s40265-019-01071-7
- By:
- Publication type:
- Article
Peripheral T cell cytotoxicity predicts T cell function in the tumor microenvironment.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-39345-5
- By:
- Publication type:
- Article
Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 12, p. 1894, doi. 10.2967/jnumed.118.208041
- By:
- Publication type:
- Article
EXTH-32. TRANSGENIC EXPRESSION OF IL15 IMPROVES THE EFFICACY OF CAR T CELLS IN AN IMMUNE COMPETENT GLIOBLASTOMA MODEL.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi92, doi. 10.1093/neuonc/noy148.381
- By:
- Publication type:
- Article
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape.
- Published in:
- 2016
- By:
- Publication type:
- journal article
T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies.
- Published in:
- Scientific Reports, 2016, p. 27130, doi. 10.1038/srep27130
- By:
- Publication type:
- Article
Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 125, n. 2, p. 307, doi. 10.1007/s11060-015-1905-z
- By:
- Publication type:
- Article
Response to 'In vivo secretion of anti-CD3 × anti-tumor bispecific antibodies by gene-modified cells: over a decade of T-cell engagement'.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 4, p. 613, doi. 10.1038/mt.2015.37
- By:
- Publication type:
- Article
The Narrow-Spectrum HDAC Inhibitor Entinostat Enhances NKG2D Expression Without NK Cell Toxicity, Leading to Enhanced Recognition of Cancer Cells.
- Published in:
- Pharmaceutical Research, 2015, v. 32, n. 3, p. 779, doi. 10.1007/s11095-013-1231-0
- By:
- Publication type:
- Article
Engager T Cells: A New Class of Antigen-specific T Cells That Redirect Bystander T Cells.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 1, p. 171, doi. 10.1038/mt.2014.156
- By:
- Publication type:
- Article
Changing the Mindset in Life Sciences Toward Translation: A Consensus.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 264, p. 1, doi. 10.1126/scitranslmed.aaa0599
- By:
- Publication type:
- Article
T-Cell Immunotherapy: Looking Forward.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 9, p. 1564, doi. 10.1038/mt.2014.148
- By:
- Publication type:
- Article
Harnessing the Immune System to Potentiate Oncolytics.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 2, p. 239, doi. 10.1038/mt.2013.295
- By:
- Publication type:
- Article
Design and development of therapies using chimeric antigen receptor-expressing T cells.
- Published in:
- Immunological Reviews, 2014, v. 257, n. 1, p. 107, doi. 10.1111/imr.12131
- By:
- Publication type:
- Article
T-cell Engager-armed Oncolytic Vaccinia Virus Significantly Enhances Antitumor Therapy.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 1, p. 102, doi. 10.1038/mt.2013.240
- By:
- Publication type:
- Article
Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 1, p. 132, doi. 10.1038/mt.2013.242
- By:
- Publication type:
- Article
Genetically modified T cells to target glioblastoma.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00322
- By:
- Publication type:
- Article
A Vaccine That Co-Targets Tumor Cells and Cancer Associated Fibroblasts Results in Enhanced Antitumor Activity by Inducing Antigen Spreading.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0082658
- By:
- Publication type:
- Article
Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 11, p. 2113, doi. 10.1038/mt.2013.151
- By:
- Publication type:
- Article
Antitumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 8, p. 1611, doi. 10.1038/mt.2013.110
- By:
- Publication type:
- Article
T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 3, p. 629, doi. 10.1038/mt.2012.210
- By:
- Publication type:
- Article
Aggressive peripheral CD70-positive t-cell lymphoma associated with severe chronic active EBV infection.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 59, n. 4, p. 758, doi. 10.1002/pbc.23352
- By:
- Publication type:
- Article
Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 8, p. 1622, doi. 10.1038/mt.2012.130
- By:
- Publication type:
- Article
PiggyBac-mediated Cancer Immunotherapy Using EBV-specific Cytotoxic T-cells Expressing HER2-specific Chimeric Antigen Receptor.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2133, doi. 10.1038/mt.2011.131
- By:
- Publication type:
- Article
Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2258, doi. 10.1038/mt.2011.167
- By:
- Publication type:
- Article
Crosstalk between Medulloblastoma Cells and Endothelium Triggers a Strong Chemotactic Signal Recruiting T Lymphocytes to the Tumor Microenvironment.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0020267
- By:
- Publication type:
- Article
A Th1-inducing Adenoviral Vaccine for Boosting Adoptively Transferred T Cells.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 1, p. 211, doi. 10.1038/mt.2010.223
- By:
- Publication type:
- Article
Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1779, doi. 10.1038/mt.2009.133
- By:
- Publication type:
- Article
Clinical and Virological Characteristics of Patients with Chronic Active Epstein-Barr Virus Infection Treated with Hematopoietic Stem Cell Transplantation: Insights and Questions.
- Published in:
- Clinical Infectious Diseases, 2008, v. 46, n. 10, p. 1535, doi. 10.1086/587665
- By:
- Publication type:
- Article